Structure Medical, LLC

Structure Medical, LLC is a manufacturer focused on producing specialized medical implants and instruments for the musculoskeletal system. Their offerings are designed to enhance surgical outcomes and advance healthcare. Founded in 2004 and headquartered in Naples, US, Structure Medical, LLC specializes in spine, trauma, and arthroscopic medical implant products. The company was acquired by Squadron Capital in February 2010, though financial terms were not disclosed.

The CEO, Robert Boody, leads the company, continuing to build on its foundations in advanced manufacturing and B2B transactions. Structure Medical is a prominent manufacturer specializing in spine, trauma, and arthroscopic medical implant products designed to address various musculoskeletal system issues. Their core offerings include innovative implants, precision-built medical instruments, and cutting tools that facilitate intricate surgical procedures. The implants produced by Structure Medical are utilized in treating conditions such as trauma, tumors, sports injuries, degenerative diseases, and congenital disorders, significantly improving patient outcomes.

Their client base primarily consists of top-tier Original Equipment Manufacturers (OEMs) who distribute these products across North America, Europe, and select markets in Asia. The company's commitment to advanced manufacturing processes enables them to meet the diverse needs of their end-users, including medical professionals and patients requiring specialized surgical interventions. Structure Medical generates revenue through business-to-business transactions with OEMs, supplying a range of medical devices tailored to specific clinical applications. The company operates on a contractual basis, ensuring that products are developed and manufactured according to the unique specifications provided by their clients.

These transactions typically involve the delivery of products that align with customers' forecasts, particularly through their Vendor-Managed Inventory program. This model allows clients to maintain a steady supply of medical implants and instruments while minimizing the financial impact of unsold inventory. The flagship products, which include advanced implants and precision instruments, are priced based on their complexity and manufacturing requirements, reflecting the high standards of quality and technology that Structure Medical upholds. Looking ahead, Structure Medical is focused on launching new products aimed at enhancing surgical precision and patient recovery.

The company plans to expand its market presence in regions across Asia by 2025. Recent funding from Squadron Capital is expected to support these initiatives by providing the necessary resources for product development and market penetration. The strategic move to take advantage of the emerging markets is part of their comprehensive growth strategy.